Western African Ebola virus epidemic
Western African Ebola virus epidemic[edit | edit source]
Western African Ebola virus epidemic is a major outbreak of Ebola virus disease (EVD) that primarily affected three countries in West Africa: Guinea, Liberia, and Sierra Leone. The epidemic began in Guinea in December 2013, then spread to Liberia and Sierra Leone, with minor outbreaks occurring elsewhere. It caused significant mortality, with the Case fatality rate varying between 25% and 90% in past outbreaks, and averaging about 50%.
Background[edit | edit source]
Ebola virus disease (EVD) is a severe, often fatal illness in humans. The virus is transmitted to people from wild animals and spreads in the human population through human-to-human transmission. The average EVD case fatality rate is around 50%. Case fatality rates have varied from 25% to 90% in past outbreaks.
Outbreak[edit | edit source]
The epidemic began in Guinea in December 2013, then spread to Liberia and Sierra Leone. Other minor outbreaks occurred in Nigeria, Mali and the United States. The World Health Organization (WHO) declared the epidemic to be a public health emergency of international concern in August 2014.
Response[edit | edit source]
The response to the epidemic included measures to prevent and control the spread of infections, manage cases, communicate risk and mobilize communities, and coordinate the response. The World Health Organization (WHO), Doctors Without Borders (MSF), and other international organizations were involved in the response.
Impact[edit | edit source]
The epidemic had a significant impact on the affected countries. It caused significant mortality, with the case fatality rate varying between 25% and 90% in past outbreaks, and averaging about 50%. The epidemic also had significant social, economic, and political impacts in Guinea, Liberia, and Sierra Leone.
See also[edit | edit source]
| Western African Ebola virus epidemic Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Kondreddy Naveen
